A Randomized, Multi-center, Phase 3 Study of Nivolumab in Combination with Ipilimumab Compared to Sorafenib or Lenvatinib as First-Line Treatment in Participants with Advanced Hepatocellular Carcinoma.

  • Roberts, Stuart (Primary Chief Investigator (PCI))
  • Lewis, Paula (Project Manager)
  • George, Jacob (Chief Investigator (CI))
  • Zekry, Amany (Chief Investigator (CI))
  • O’Beirne, James (Chief Investigator (CI))
  • Tse, Edmund (Chief Investigator (CI))
  • McLachlan, Sue Anne (Chief Investigator (CI))
  • Eastgate, Melissa (Chief Investigator (CI))
  • Ananda, Sumitra (Chief Investigator (CI))
  • Davison, Scott (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date24/09/19 → 30/09/23

Keywords

  • Gastroenterology
  • Hepatocellular Carcinoma
  • Clinical trial

Clinical Trial Phase

  • Phase III (a & b)